ClinicalTrials.Veeva

Menu

Lung Transplantation for Pleuroparenchymal Fibroelastosis

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Fibroelastosis

Treatments

Procedure: Lung transplantation (single, lobar or bilateral lung transplantation)

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This retrospective observational study will evaluate the outcomes of lung transplantation for a rare cause of interstitial lung disease called pleuroparenchymal fibroelastosis. Data will be collected from all transplantation center in France.

Enrollment

30 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Lung transplantation (any type) for pleuroparenchymal fibroelastosis
  • Histologically confirmed pleuroparenchymal fibroelastosis on the recipient lungs

Exclusion criteria

  • All other interstitial lung disease than pleuroparenchymal fibroelastosis
  • Pleuroparenchymal fibroelastosis who didn't underwent lung transplantation

Trial design

30 participants in 1 patient group

lung transplantation
Description:
Lung transplantation performed for end-stage interstitial lung disease secondary to pleuroparenchymal fibroelastosis.
Treatment:
Procedure: Lung transplantation (single, lobar or bilateral lung transplantation)

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems